RJ

Ronak Jangir

Active Director Director DIN 09632958
DIN 09632958 First appointment Jun 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Ronak Jangir

Data last updated:

Ronak Jangir is a Director at Docsy Medtech Private Limited (since 2022). The company operates in Healthcare. Docsy Medtech Private Limited reported revenue of ₹14.2 Lakh (FY 2024).

DIN 09632958
Primary Designation Director
Industry Healthcare
First Appointment 09 Jun 2022
Oldest Company Age 4 yrs
Largest company Docsy Medtech Private Limited · ₹14.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Docsy Medtech Private Limited U72900RJ2022PTC081891
Director09 Jun 20222022₹14.2 Lakh (FY 2024)Active

Board colleagues of Ronak Jangir

NameDINCompanyDesignation
Advay Atul Aundhekar09632957Docsy Medtech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Docsy Medtech Private Limited
Premium access

Shareholding and investment profile for Ronak Jangir

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ronak Jangir

Ronak Jangir currently holds 1 directorship: Docsy Medtech Private Limited (Director, since 09 Jun 2022, revenue ₹14.2 Lakh (FY 2024)).

Ronak Jangir was first appointed on 09 Jun 2022 as Director at Docsy Medtech Private Limited.

The current boards of Ronak Jangir's companies include Advay Atul Aundhekar (Docsy Medtech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available